LiveOpenAI Raises $11 Billion So Far at a $1.25 Trillion Valuation, Short of Its $30 Billion Goal
    WYDE
    Sign inSubscribe
    WYDE Newsroom Submit
    company

    Science Corporation

    Science Corporation is a clinical-stage medical technology company that develops brain-computer interface (BCI) technology. It is working to commercialize the PRIMA BCI retinal implant.

    science.xyz
    Co-Founder and CEO
    Max Hodak

    Leadership

    Max Hodak, Co-Founder and CEO. Max Hodak is an American entrepreneur and biomedical engineer.

    Key facts

    Founded
    2021source
    Series C
    Oversubscribed $230 million Series C financing roundsource
    Total capital raised since founding
    approximately $490 millionsource
    Series C investors
    Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital, among otherssource
    Category
    Clinical-stage medical technology companysource

    WYDE coverage of Science Corporation

    WYDE Newsroom has published 2 articles about Science Corporation, from Jul 23, 2026 to Jul 25, 2026. Science Corporation is the subject of 2 stories. The most recent is Global hunger fell to 645 million, lawmakers introduced an AI kill switch, and a judge approved Anthropic's $1.5 billion settlement. Over 60,000 meals..

    WYDE Weekly

    Global hunger fell to 645 million, lawmakers introduced an AI kill switch, and a judge approved Anthropic's $1.5 billion settlement. Over 60,000 meals.

    WYDE Weekly: the UN's third straight drop in global hunger to 645 million, the AI Kill Switch and FRONTIER oversight bills, a judge's approval of Anthropic's $1.5 billion settlement, a record 55,362 schools serving free meals, and a GAO finding of up to $521 billion in yearly federal fraud.

    Jul 25, 2026 · 7 min read · Subject of the story

    Healthcare

    Science Corporation Launches PRIMA, a Vision-Restoring Retinal Implant, in Europe

    Science Corporation won a CE mark for PRIMA, a retinal implant that restored functional central vision in most trial patients with age-related macular degeneration, and is launching it across Europe.

    Jul 23, 2026 · 2 min read · Subject of the story

    Reported alongside Science Corporation

    Sources

    Track the institutions that move money.

    Data-driven coverage, every week.